tiprankstipranks
AlloVir Approves Executive Bonuses for Potential 2024 Buyout
PremiumCompany AnnouncementsAlloVir Approves Executive Bonuses for Potential 2024 Buyout
7M ago
SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors
Premium
Class Action
SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors
10M ago
AlloVir Faces Delisting Risk, Considers Reverse Split to Comply
Premium
Company Announcements
AlloVir Faces Delisting Risk, Considers Reverse Split to Comply
11M ago
Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
PremiumThe FlyKaruna downgraded, Arm target raised: Wall Street’s top analyst calls
1y ago
AlloVir downgraded to Underperform from Buy at BofA
Premium
The Fly
AlloVir downgraded to Underperform from Buy at BofA
1y ago
AlloVir downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
AlloVir downgraded to Equal Weight from Overweight at Morgan Stanley
1y ago
AlloVir downgraded to Underweight from Overweight at JPMorgan
PremiumThe FlyAlloVir downgraded to Underweight from Overweight at JPMorgan
1y ago
AlloVir to discontinue three global Phase 3 posoleucel studies
Premium
The Fly
AlloVir to discontinue three global Phase 3 posoleucel studies
1y ago
AlloVir reports Q3 EPS (39c), consensus (42c)
Premium
The Fly
AlloVir reports Q3 EPS (39c), consensus (42c)
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100